Pierre Fabre Laboratories’ Post

Dr. Benjamin Stanton at The Research Institute at Nationwide and his team have published the first comprehensive 3D analysis of the #rhabdomyosarcoma genome. This 3D analysis helped them find factors that control how the cancer grows and how certain genes work together. This breakthrough could lead to better treatments for this challenging #cancer. The 2023 grant for this research is supported by Berry Strong, a St. Baldrick’s Hero Fund honoring Caroline, who bravely fought rhabdomyosarcoma and raised awareness for childhood cancer #research. Read more about major breakthroughs made possible by St. Baldrick’s funding: https://ow.ly/yjR350SBKg5 #ChildhoodCancer #SarcomaAwarenessMonth #researchmatters

News from Cancer Research UK: How can we share research together? A co-creation project to make scientific research more accessible In this mini-series of three articles, we share a recent PPIE project where we co-created an accessible information sheet based on a journal paper. In this article the PPI co-ordinator, Lisa Whittaker and one of the researchers, Catarina Veiga give an overview of the project and share their experiences of being involved. The post How can we share research together? A co-creation project to make scientific research more accessible appeared first on Cancer Research UK - Cancer News. 👉🏽👉🏽 https://lnkd.in/eRGnuyNb #fundraising #relayforlife #cancerresearchuk #savinglives

💥 Congratulations to the five research teams that have been chosen to tackle the most demanding challenges in the field of cancer research! ⚙ As part of #CRUK, we are determined to accelerate cancer discoveries. For 40 years scientists from academic universities and leading cancer centres have deposited their research tools with us. These range from antibodies, cell lines, organoids, small molecules, mouse models, cell culture media, proteins, vectors and other state-of- the-art technologies. ➡️ Click on the link below to learn more about the most recent funding round and get to know the teams. #cancertoolsorg #cancerresearch #lifesciences #cancergrandchallenges

The Lung Cancer Research Foundation (LCRF) is a nonprofit organization with the mission of improving lung cancer outcomes by funding research for the prevention, diagnosis, treatment, and cure of lung cancer. In this inspiring interview, Dr. Antoinette Wozniak, Chief Scientific Officer of LCRF, outlines the grant opportunities available through LCRF, mentions a successful recipient's profile as an example, and provides advice for researchers interested in applying. If you're eager to delve into the incredible grant opportunities offered by the Lung Cancer Research Foundation, this interview is a must-read! ⬇ https://lnkd.in/dYMTFE8d We've translated this interview to Spanish and Portuguese! #LungCancer #LungCancerResearch #LCRF #ResearchFunding #scientifyRESEARCH

Great podcast episode focusing on the burden of cancer globally.

💡Did you know that researchers from SME´s can also apply for canSERV services? #canSERV_EU partner EATRIS presented information about canSERV and the cancer research services to the cancer innovation community at 4YFN, a start up event in Barcelona. Did you miss it? Find out more about how your SME can profit from free cancer research services here: https://lnkd.in/ejMQMds2 Apply for the canSERV research services by May 21. #cancerresearch #SME #researchservices #EUcancermission #EUbeatingcancerplan

✨ Research Spotlight from St. Baldrick’s Annual Report ✨ The Pediatric Cancer Data Commons (PCDC) houses the world’s largest set of harmonized clinical data for pediatric #cancer #research. With hundreds of international collaborators forming more than ten disease-specific consortia, they have collected and harmonized data from across more than forty countries and almost all types of pediatric cancer, allowing researchers easy access to this diverse data. The St. Baldrick’s Foundation has proudly provided essential support for the development and launch of the PCDC data portal and analysis tools. The #researchers, who have already made their data available for research, are driving new science and publishing their discoveries. More than 90 papers have been published using data from the PCDC or consensus opinions developed by the consortium experts. If you’ve supported St. Baldrick’s, then you’ve made this possible! Thank you! Like & share to spread your impact. #childhoodcancer #childhoodcancerawareness #researchishope #researchmatters #teamwork

Diversity in clinical trials is essential to understanding a treatment's effectiveness across different populations. 🌍 Check out how a recent study highlights the representation of various groups in trials conducted at National Cancer Institute (NCI)'s Center for Cancer Research. “By including every population in a clinical trial, you can have higher confidence to say who will benefit from a certain therapy,” explains Charalampos “Harris” Floudas, M.D., DMSc, M.S., Assistant Research Physician in the Center for Immuno-Oncology. Learn more: https://lnkd.in/ebKth2Hv #Diversity #Medicine #Science #Cancer #NonProfit

𝗥𝗲𝘁𝘂𝗿𝗻 𝘁𝗼 𝗪𝗼𝗿𝗸 𝗖𝗮𝗻𝗰𝗲𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 Hannover Re is hosting a global webinar on 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆 𝟮𝟲 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿, to share the findings of their scoping review and White Paper on the challenges in cancer survivorship and practical recommendations to improve cancer survivors returning to work, done in partnership with Griffith University. This study canvasses global and local research about cancer survivors’ challenges and barriers in returning to work. Find out more and register here: https://lnkd.in/gYTvfFnE

🎉Congrats to Winship researcher Canhua Xiao, PhD, RN, FAAN, on being awarded a $3.3M grant from the National Cancer Institute (NCI) to study the psychosocial impacts of immunotherapy for advanced head and neck cancer patients. Conducted with other Winship collaborators, this vital research will explore how biological and social factors influence patients' quality of life and survival, bringing hope for better care. 🌟 ➡️Learn more: https://brnw.ch/21wN3kL